Jump to content

  • Set Your Location
  • Sign in or Enroll
Set Your LocationEden Medical Center
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Eden
  • Research
  • Investigators
  • Mohammed Kashani-Sabet
Content

Investigator Mohammed Kashani-Sabet, M.D.

Mohammed Kashani-Sabet, M.D.

View profile  
Recent cDNA microarray analyses of moles and primary and metastatic melanomas performed by Dr. Kashani’s laboratory have identified a number of genes whose expression levels can be used to distinguish between known landmarks in the tumor progression cascade of melanoma. The lab has identified novel biomarkers associated with each stage of melanoma progression, and has described a molecular diagnostic assay for melanoma that yields sensitivity, specificity and diagnostic accuracy of greater than 90% in the diagnosis of melanocytic neoplasms. Researchers at CPMCRI have already identified a number of targets implicated in tumor proliferation or invasion; studies are underway in the Kashani lab to assess activation of these targets and their signaling pathways in the context of known molecular subtypes, to identify further enriched targets.  Dr. Kashani leads CPMC’s Center for Melanoma Research and Treatment, and he is the primary investigator for a new integrated research program at CPMCRI seeking to develop effective combination therapies for aggressive and metastatic tumors, including melanomas, breast cancers and glioblastomas.


Sutter Health Research Enterprise
2340 Clay Street, 2nd Floor
San Francisco, CA, 94115
(415) 600-3800  
kashani@sutterhealth.org

Primary Research Interests

  • Cancer

Research Studies

Cancer Liquid Biopsy Monitoring Study

A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung c

Investigators: Deepti Behl MD, Mohammed Kashani-Sabet M.D.

The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

  • Contact Us
  • Find Doctors
  • Find Locations
  • Request Medical Records
  • Make a Gift
Sign in to My Health Online

Billing and Insurance

  • Pay a Bill
  • Accepted Health Plans
  • Estimate Costs
  • Medicare Advantage

About Sutter

  • About Our Network
  • Community Benefit
  • Annual Report
  • News

Our Team

  • For Employees
  • For Medical Professionals
  • For Vendors
  • For Volunteers

Careers

  • Jobs at Sutter
  • Physician Jobs
  • Graduate Medical Education

Copyright © 2023 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

  • ADA Accessibility
  • Privacy
  • Do Not Sell My Personal Information
  • LinkedIn Opens new window
  • YouTube Opens new window
  • Facebook Opens new window
  • Twitter Opens new window
  • Instagram Opens new window
  • Glassdoor Opens new window

Cookie Policy

We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

Privacy Policy Cookie Preferences